Shopping Cart 0
Cart Subtotal
USD 0

University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

The University of Melbourne is an educational service provider that offers graduate, postgraduate, and research degrees. The university offers education in various fields which include arts, engineering, business and economics, architecture, building and planning, land and environment, medical, dentistry, information and technology, education, and health science, law, veterinary science, among others. It also offers awareness and management services to the society in the field of research and teaching services. The university's health services comprise contraception, sexually transmitted infections, women's health, men's health, and others. It also offers research programs. The University of Melbourne is headquartered in Parkville, Victoria, Australia.

University of Melbourne-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Melbourne, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Melbourne, Medical Devices Deals, 2012 to YTD 2018 10

University of Melbourne, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Melbourne, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Clarity Pharma Raises USD1.4 Millon in Financing Round 13

Hatchtech Raises USD 12 Million In Venture Financing 14

Hatchtech Raises USD 6.3 Million In Venture Financing 15

Partnerships 16

University of Melbourne Enters Into Agreement With Procypra To Develop Drugs For Neurological Diseases 16

Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 17

Telix Pharma Enters into Research Partnership with University of Melbourne and Peter MacCallum Cancer Centre 18

TargImmune Therapeutics Enters into Research Agreement with Walter and Eliza Hall Institute 19

Patrys and Walter and Eliza Hall Institute of Medical Research Enter into Collaboration 20

International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 21

Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 22

Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 23

Janssen-Cilag Enters Into Research Agreement With University of Melbourne 24

Servier Enters Into R&D Agreement With Florey Institute of Neuroscience and Mental Health 25

Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 27

Licensing Agreements 28

Clarity Pharma Enters into Licensing Agreement with University of Melbourne 28

Telix Pharma Enters into Licensing Agreement with University of Melbourne 29

Janssen Pharma Enters into Licensing Agreement with St Vincent's Institute of Medical Research 30

TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 31

Asset Transactions 33

CPPIB Credit Europe Acquires Partial Royalty Rights for Venetoclax from Walter and Eliza Hall Institute of Medical Research 33

University of Melbourne-Key Competitors 34

University of Melbourne-Key Employees 35

University of Melbourne-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Joint Venture 37

Recent Developments 38

Government and Public Interest 38

Aug 22, 2018: Newly identified drug target in rheumatoid arthritis paves the way for the development of new therapies 38

Aug 01, 2018: Accelerating stem cell discoveries into tomorrow's medicine 39

Jun 21, 2018: New treatment helps avoid deafness in child chemotherapy patients 40

Jun 06, 2018: Real-time, web-based tool to revolutionise drug-resistant TB treatment 41

May 01, 2018: NHMRC Partnership Grant awarded to University of Melbourne Collaborators Aims to S ubstantially Improve Breast Cancer Risk Prediction and Increase Accessibility 42

May 01, 2018: Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility 43

Apr 26, 2018: University of Melbourne receives USD 6.15M NHMRC grants 44

Feb 28, 2018: Familial breast cancer not only inherited genetically, finds new study 45

Feb 06, 2018: New liver cancer study trials SABR treatment 46

Dec 13, 2017: USD 5m gift for medical research with Galli Chair in Medical Biology 47

Sep 18, 2017: Li Ka Shing Foundation donates USD 3m for precision oncology 49

Aug 17, 2017: New Way To Empower The Immune System To Detect And Kill Cancer 50

Other Significant Developments 51

Aug 27, 2018: MS Researchers find new ways to regenerate the brain's insulation 51

Mar 29, 2018: Towards greater MRI sensitivity by harnessing quantum hyperpolarisation 52

Mar 15, 2018: Virtual Reality facility helping patients recover from injuries 54

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55


List Of Figure

List of Figures

University of Melbourne, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Melbourne, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Melbourne, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Melbourne, Pharmaceuticals & Healthcare, Key Facts 2

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Melbourne, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Melbourne, Deals By Therapy Area, 2012 to YTD 2018 9

University of Melbourne, Medical Devices Deals, 2012 to YTD 2018 10

University of Melbourne, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Clarity Pharma Raises USD1.4 Millon in Financing Round 13

Hatchtech Raises USD 12 Million In Venture Financing 14

Hatchtech Raises USD 6.3 Million In Venture Financing 15

University of Melbourne Enters Into Agreement With Procypra To Develop Drugs For Neurological Diseases 16

Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 17

Telix Pharma Enters into Research Partnership with University of Melbourne and Peter MacCallum Cancer Centre 18

TargImmune Therapeutics Enters into Research Agreement with Walter and Eliza Hall Institute 19

Patrys and Walter and Eliza Hall Institute of Medical Research Enter into Collaboration 20

International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 21

Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 22

Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 23

Janssen-Cilag Enters Into Research Agreement With University of Melbourne 24

Servier Enters Into R&D Agreement With Florey Institute of Neuroscience and Mental Health 25

Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 27

Clarity Pharma Enters into Licensing Agreement with University of Melbourne 28

Telix Pharma Enters into Licensing Agreement with University of Melbourne 29

Janssen Pharma Enters into Licensing Agreement with St Vincent's Institute of Medical Research 30

TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 31

CPPIB Credit Europe Acquires Partial Royalty Rights for Venetoclax from Walter and Eliza Hall Institute of Medical Research 33

University of Melbourne, Key Competitors 34

University of Melbourne, Key Employees 35

University of Melbourne, Other Locations 36

University of Melbourne, Subsidiaries 36

University of Melbourne, Joint Venture 37

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Melbourne, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.